Agilent Technologies’ Thought Leader Award Supports Dr. Robert Gerszten’s Work in Metabolomic Research at Massachusetts

  Agilent Technologies’ Thought Leader Award Supports Dr. Robert Gerszten’s
  Work in Metabolomic Research at Massachusetts General Hospital

Business Wire

SANTA CLARA, Calif. -- December 18, 2012

Agilent Technologies Inc. (NYSE: A) today announced that Dr. Robert Gerszten,
a recognized leader in cardiovascular research and biomarker discovery, has
received an Agilent Thought Leader Award.

Dr. Robert Gerszten, a recognized leader in cardiovascular research and
biomarker discovery, has rec ...

Dr. Robert Gerszten, a recognized leader in cardiovascular research and
biomarker discovery, has received an Agilent Thought Leader Award. (Photo:
Business Wire)

Dr. Gerszten is the director of clinical and translational research at
Massachusetts General Hospital’s Institute for Heart, Vascular and Stroke
Care. The award will provide his laboratory with funding for personnel.
Agilent will also provide technical and scientific expertise in metabolomics,
automation and integrated biology in support of Dr. Gerszten’s metabolite
profiling study of well-phenotyped human populations, including his work with
the Framingham Heart Study.

“Our goal is to identify new metabolites and proteins that mark disease
activity, signal disease progression, and ultimately provide targets for
therapeutic intervention,” said Dr. Gerszten. “We are grateful that Agilent
supports our research and is helping us in our quest to advance translational
cardiology.”

“Agilent is proud to support Dr. Gerszten’s research in this pivotal project
and further advance progress in the important field of cardiometabolic
diseases,” said Agilent CTO Darlene Solomon, the executive sponsor of the
award. “By providing support and cutting-edge technologies to leading
translational researchers like Dr. Gerszten, we aim to facilitate innovative
research and to progress the fields of metabolomics and integrated biology
toward improved patient outcomes.”

The Agilent Thought Leader Award program promotes fundamental advances by
contributing philanthropic financial support, products and expertise to the
research of thought leaders in the life sciences and chemical analysis.
Information about previous recipients is available at
www.agilent.com/univ_relation/TLP/index.shtml.

Massachusetts General Hospital, founded in 1811, is the original and largest
teaching hospital of Harvard Medical School.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news
are available at www.agilent.com/go/news.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20121218005231/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50510554&lang=en

Contact:

Agilent Technologies Inc.
Eric Endicott, +1 408-553-2005
eric_endicott@agilent.com
 
Press spacebar to pause and continue. Press esc to stop.